Yes! But the accompanying stock market race and patent protection is questionable... --- I know it's a different issue... I totally agree Biontech is a great story, which might be an inspiring one for further vaccine research (a topic relatively neglected by Pharma, for the obvious reason that it's a business where you loose your customers...). Nevertheless, I'm questioning the $$$$ coming with this success, in the context of global shortage. There have been times where I made "fun" out of making more money with buying/selling at the right time vaccine-shares than working as a frontline worker, eventually putting myself at danger (but still, I found more satisfaction with the later..). The "right timing" had by the way nothing to do with the real life development, what made me leaving the game. What we should not forget is that this success would have been impossible without government =taxpayers money. But I never heard Germany got anything back from this success (except indirectly via taxes). And not to forget: this story is also why Germany was for protecting vaccine patent -against WHO request...

Source author: Katharina Beyer katharina.beyer@etu.unige.ch